A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention
Clinical trial NCT04848220 · TERMINATED
Trial details
- NCT number
- NCT04848220
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-20
- Primary completion
- 2022-08-23
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.